The ratio of heart-type fatty acid-binding protein (hFABP) to myoglobin, combined with BNP, improved detection of cardiac damage and volume overload in dialysis patients beyond either marker alone.
Multi-marker improvementNo single marker was perfect in dialysis patients — combining hFABP/myoglobin ratio + BNP captured both damage AND overload better than any alone
What the researchers found
The hFABP/myoglobin ratio combined with BNP improved detection of cardiac damage and volume overload in dialysis patients, providing a multi-marker approach that overcomes renal clearance confounding of individual markers.
Why it matters
Single biomarkers have limitations in kidney failure patients. Multi-marker approaches that account for renal confounding improve diagnostic accuracy for this extremely high-risk population.
How the study worked
Cross-sectional study in dialysis patients. hFABP, myoglobin, BNP, ANP, and cardiac function parameters measured. The hFABP/myoglobin ratio developed to normalize for renal clearance effects.
What this study cannot tell us
Cross-sectional design. The specific hFABP/myoglobin ratio cutoffs need validation. Dialysis timing affects all markers.
How to read the evidence
Moderate evidence from a comparative biomarker study in a clinically challenging population with novel ratio development.
When this study was published
Published in 2003. Multi-marker cardiac assessment in renal failure patients has evolved with additional novel biomarkers.
The bigger picture
Precision diagnostics in complex patients requires multi-marker panels that account for confounding factors. This approach models how cardiac biomarker science evolves for challenging populations.
Questions still open
- Should multi-marker panels be standard in dialysis patient cardiac assessment?
- Does the ratio predict cardiac events in dialysis patients?
- Can this approach reduce unnecessary cardiac testing in dialysis?
Common questions
Why are heart tests harder in dialysis patients?
Should dialysis patients get multiple heart markers?
Read the original research
Serum ratio of heart-type fatty acid-binding protein to myoglobin. A novel marker of cardiac damage and volume overload in hemodialysis patients.
Nephron. Clinical practice, 93(2), C69-74
Citation
Furuhashi, Masato; Ura, Nobuyuki; Hasegawa, Koichi; Yoshida, Hideaki; Tsuchihashi, Kazufumi; Nakata, Tomoaki; Shimamoto, Kaxuaki. (2003). Serum ratio of heart-type fatty acid-binding protein to myoglobin. A novel marker of cardiac damage and volume overload in hemodialysis patients.. Nephron. Clinical practice, 93(2), C69-74.